C9149 Injection, teplizumab-mzwv, 5 mcg

Short descriptor: Inj, teplizumab-mzwv, 5 mcg

⚠ Terminated HCPCS Level II 2026
Terminated Code
C9149 was terminated as of 2023-06-30 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open C9149 in the app →

Look up C9149 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

C9149 is the HCPCS Level II code for Injection, teplizumab-mzwv, 5 mcg (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Statute (indicator 53)
Type of Service
Medical care
Effective Date
2023-07-01
Termination Date
2023-06-30
2026 Maintenance
No change this year

References

Cite This Page

Reference C9149 with the canonical source and edition:

C9149 — Injection, teplizumab-mzwv, 5 mcg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9149

Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9149

Related Codes in Section C

← C9148 Inj, teclistamab-cqyv, 0.5mg C9150 → Xe129 xenon, diagnostic
C9145 Inj, aponvie, 1 mg C9146 Inj, elahere, 1 mg C9147 Inj, tremelimumab-actl, 1 mg C9148 Inj, teclistamab-cqyv, 0.5mg C9150 Xe129 xenon, diagnostic C9151 Inj, pegcetacoplan 1 mg C9152 Inj, abilify asimtufii, 1 mg C9153 Inj, amisulpride, 1 mg C9154 Inj buprenorph (brixadi) 1mg C9155 Inj epcoritamab-bysp,0.16 mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial